Sex-specific alterations in the gut and lung microbiome of allergen-induced mice.

IF 3.3 Q2 ALLERGY
Frontiers in allergy Pub Date : 2024-08-15 eCollection Date: 2024-01-01 DOI:10.3389/falgy.2024.1451846
Carolyn Damilola Ekpruke, Rachel Alford, Dustin Rousselle, Maksat Babayev, Shikha Sharma, Erik Parker, Kyle Davis, Christopher Hemmerich, Douglas B Rusch, Patricia Silveyra
{"title":"Sex-specific alterations in the gut and lung microbiome of allergen-induced mice.","authors":"Carolyn Damilola Ekpruke, Rachel Alford, Dustin Rousselle, Maksat Babayev, Shikha Sharma, Erik Parker, Kyle Davis, Christopher Hemmerich, Douglas B Rusch, Patricia Silveyra","doi":"10.3389/falgy.2024.1451846","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Recent evidence has demonstrated that the microbiome is a driver of the underlying pathophysiological mechanisms of respiratory disease. Studies have indicated that bacterial metabolites produced in the gut and lung can impact lung inflammation and immune cell activity, affecting disease pathology. Despite asthma being a disease with marked sex differences, experimental work linking microbiomes and asthma has not considered the sex variable.</p><p><strong>Methods: </strong>To test the hypothesis that the lung and gut microbial composition impacts allergic lung inflammation in a sex-specific manner, we evaluated lung and gut microbiome alterations in a mouse model of allergic inflammation and assessed their association with lung function and inflammation phenotypes. For this, we exposed male and female adult C57BL/6J mice intranasally to 25 µg of a house dust mite extract mix (HDM) daily, or phosphate-buffered saline (PBS) as control, for 5 weeks (<i>n</i> = 4-6/group). DNA from fecal pellets collected before and after the 5-week treatment, and from lung tissue collected at endpoint, was extracted using the ZymoBIOMICS®-96 MagBead DNA Kit and analyzed to determine the 16S microbiome via Targeted Metagenomic Sequencing.</p><p><strong>Results: </strong>The HDM treatment induced a sex-specific allergic inflammation phenotype with significantly higher neutrophilia, lymphocytosis, inflammatory gene expression, and histopathological changes in females than males following exposure to HDM, but higher airway hyperresponsiveness (AHR) in males than females. In addition, sex-specific lung gene expression and associated pathways were identified HDM mix after challenge. These changes corresponded to sex-specific alterations in the gut microbiome, where the <i>Firmicutes</i> to <i>Bacteroidetes</i> ratio (F:B) was significantly reduced in fecal samples from only male mice after HDM challenge, and alpha diversity was increased in males, but decreased in females, after 5-weeks of HDM treatment.</p><p><strong>Discussion: </strong>Overall, our findings indicate that intranasal allergen challenge triggers sex-specific changes in both gut and lung microbiomes, and induces sex-specific lung inflammation, AHR, and lung inflammatory gene expression pathways, suggesting a contribution of the lung-gut axis in allergic airway disease.</p>","PeriodicalId":73062,"journal":{"name":"Frontiers in allergy","volume":"5 ","pages":"1451846"},"PeriodicalIF":3.3000,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11358121/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in allergy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/falgy.2024.1451846","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Recent evidence has demonstrated that the microbiome is a driver of the underlying pathophysiological mechanisms of respiratory disease. Studies have indicated that bacterial metabolites produced in the gut and lung can impact lung inflammation and immune cell activity, affecting disease pathology. Despite asthma being a disease with marked sex differences, experimental work linking microbiomes and asthma has not considered the sex variable.

Methods: To test the hypothesis that the lung and gut microbial composition impacts allergic lung inflammation in a sex-specific manner, we evaluated lung and gut microbiome alterations in a mouse model of allergic inflammation and assessed their association with lung function and inflammation phenotypes. For this, we exposed male and female adult C57BL/6J mice intranasally to 25 µg of a house dust mite extract mix (HDM) daily, or phosphate-buffered saline (PBS) as control, for 5 weeks (n = 4-6/group). DNA from fecal pellets collected before and after the 5-week treatment, and from lung tissue collected at endpoint, was extracted using the ZymoBIOMICS®-96 MagBead DNA Kit and analyzed to determine the 16S microbiome via Targeted Metagenomic Sequencing.

Results: The HDM treatment induced a sex-specific allergic inflammation phenotype with significantly higher neutrophilia, lymphocytosis, inflammatory gene expression, and histopathological changes in females than males following exposure to HDM, but higher airway hyperresponsiveness (AHR) in males than females. In addition, sex-specific lung gene expression and associated pathways were identified HDM mix after challenge. These changes corresponded to sex-specific alterations in the gut microbiome, where the Firmicutes to Bacteroidetes ratio (F:B) was significantly reduced in fecal samples from only male mice after HDM challenge, and alpha diversity was increased in males, but decreased in females, after 5-weeks of HDM treatment.

Discussion: Overall, our findings indicate that intranasal allergen challenge triggers sex-specific changes in both gut and lung microbiomes, and induces sex-specific lung inflammation, AHR, and lung inflammatory gene expression pathways, suggesting a contribution of the lung-gut axis in allergic airway disease.

过敏原诱导小鼠肠道和肺部微生物群的性别特异性改变
导言:最新证据表明,微生物组是呼吸系统疾病潜在病理生理机制的驱动因素。研究表明,肠道和肺部产生的细菌代谢物会影响肺部炎症和免疫细胞的活性,从而影响疾病的病理变化。尽管哮喘是一种具有明显性别差异的疾病,但将微生物组与哮喘联系起来的实验工作并未考虑性别变量:为了验证肺部和肠道微生物组成以性别特异性方式影响过敏性肺部炎症的假设,我们评估了过敏性炎症小鼠模型中肺部和肠道微生物组的改变,并评估了它们与肺功能和炎症表型的关联。为此,我们让雄性和雌性成年 C57BL/6J 小鼠每天鼻内接触 25 µg 的屋尘螨提取物混合物(HDM),或以磷酸盐缓冲盐水(PBS)作为对照,持续 5 周(n = 4-6/组)。使用ZymoBIOMICS®-96 MagBead DNA试剂盒从5周治疗前后收集的粪便颗粒和终点时收集的肺组织中提取DNA,并通过靶向元基因组测序分析确定16S微生物组:结果:接触HDM后,女性的中性粒细胞增多、淋巴细胞增多、炎症基因表达和组织病理学变化明显高于男性,但男性的气道高反应性(AHR)高于女性。此外,还发现了挑战后混合型 HDM 的性别特异性肺基因表达和相关通路。这些变化与肠道微生物组的性别特异性改变相对应,在HDM挑战后,只有雄性小鼠粪便样本中的固着菌与类杆菌之比(F:B)显著降低,HDM处理5周后,雄性小鼠的α多样性增加,而雌性小鼠的α多样性降低:总之,我们的研究结果表明,鼻内过敏原挑战会引发肠道和肺部微生物组的性别特异性变化,并诱导肺部炎症、AHR和肺部炎症基因表达通路的性别特异性,这表明肺-肠轴在过敏性气道疾病中的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.80
自引率
0.00%
发文量
0
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信